StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.82−0.17 (-8.42%)

Close on Nov 17, 2026Market cap $2.65MP/E –Yield –

Nexentis Technologies total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Nexentis Technologies's total debt was $215.00K at Jun 30, 2026. For fiscal 2025 it was $1.42M, up 8350.5% from the year before. The highest annual figure on record is $1.42M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.42M+8350.5%
FY2021Dec 31, 2021$16.78K-30.1%
FY2020Dec 31, 2020$24.01K-18.4%
FY2019Dec 31, 2019$29.42K-65.0%
FY2018Dec 31, 2018$83.95K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$215.00K-82.5%
Q1 FY2026Mar 31, 2026$364.00K+55814.0%
Q4 FY2025Dec 31, 2025$1.42M+18.2%
Q3 FY2025Sep 30, 2025$1.22M+65777.3%
Q2 FY2025Jun 30, 2025$1.23M+32690.8%
Q1 FY2025Mar 31, 2025$651-89.5%
Q2 FY2024Jun 30, 2024$1.20M+7051.4%
Q3 FY2022Sep 30, 2022$1.86K-76.9%
Q2 FY2022Jun 30, 2022$3.75K-52.7%
Q1 FY2022Mar 31, 2022$6.20K-19.6%
Q4 FY2021Dec 31, 2021$16.78K-30.1%
Q3 FY2021Sep 30, 2021$8.05K-52.2%
Q2 FY2021Jun 30, 2021$7.93K-57.2%
Q1 FY2021Mar 31, 2021$7.71K-61.0%
Q4 FY2020Dec 31, 2020$24.01K-18.4%
Q3 FY2020Sep 30, 2020$16.84K-79.9%
Q2 FY2020Jun 30, 2020$18.53K–
Q1 FY2020Mar 31, 2020$19.77K–
Q4 FY2019Dec 31, 2019$29.42K–
Q4 FY2018Dec 31, 2018$83.95K–

More Nexentis Technologies figures

See a number that looks wrong?